VECTICAL Drug Patent Profile
✉ Email this page to a colleague
When do Vectical patents expire, and what generic alternatives are available?
Vectical is a drug marketed by Galderma Labs Lp and is included in one NDA.
The generic ingredient in VECTICAL is calcitriol. There are ten drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the calcitriol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vectical
A generic version of VECTICAL was approved as calcitriol by TEVA on October 12th, 2001.
Summary for VECTICAL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 4 |
Patent Applications: | 4,684 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VECTICAL |
What excipients (inactive ingredients) are in VECTICAL? | VECTICAL excipients list |
DailyMed Link: | VECTICAL at DailyMed |


Recent Clinical Trials for VECTICAL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Francisco | Phase 4 |
Emer, Jason, M.D. | Phase 4 |
Galderma Laboratories | Phase 4 |
Pharmacology for VECTICAL
Drug Class | Vitamin D3 Analog |
Anatomical Therapeutic Chemical (ATC) Classes for VECTICAL
US Patents and Regulatory Information for VECTICAL
VECTICAL is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting VECTICAL
NEW PATIENT POPULATION
Exclusivity Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Galderma Labs Lp | VECTICAL | calcitriol | OINTMENT;TOPICAL | 022087-001 | Jan 23, 2009 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |